Semaglutide and Cardiovascular Outcomes in Patients With Overweight or Obesity Who Do Not Have Diabetes

被引:0
|
作者
Lincoff, Abraham M. [1 ]
Brown-Frandsen, Kirstine [2 ]
Colhoun, Helen M. [3 ]
Deanfield, John [4 ]
Emerson, Scott S. [5 ]
Esbjerg, Sille [6 ]
Hardt-Lindberg, Soren [7 ]
Hovingh, G. Kees [8 ]
Kahn, Steven E. [9 ,10 ]
Kushner, Robert F. [11 ]
Lingvay, Ildiko [12 ]
Oral, Tugce Kalayci [8 ]
Michelsen, Marie M. [13 ]
Plutzky, Jorge [14 ]
Tornoee, Christoffer W. [15 ]
Ryan, Donna H. [16 ]
机构
[1] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA
[2] Novo Nordisk AS, Business Dev, Soborg, Denmark
[3] Univ Edinburgh, Inst Genet & Canc, Edinburgh, Midlothian, Scotland
[4] UCL, Dept Clin Sci, London, England
[5] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[6] Novo Nordisk AS, Dept Biostat, Soborg, Denmark
[7] Novo Nordisk AS, Project Management CKAD 5, Soborg, Denmark
[8] Novo Nordisk AS, Global Med Affairs, Soborg, Denmark
[9] VA Puget Sound Hlth Care Syst, Dept Med, Seattle, WA USA
[10] Univ Washington, Seattle, WA 98195 USA
[11] Northwestern Univ, Dept Med & Med Educ, Chicago, IL 60611 USA
[12] UT SouthWestern Med Ctr, Dept Internal Med Endocrinol, Dallas, TX USA
[13] Novo Nordisk AS, Med & Sci, Soborg, Denmark
[14] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Med Div, Boston, MA 02115 USA
[15] Novo Nordisk AS, Obes Liver Dis & Devices, Soborg, Denmark
[16] Pennington Biomed Res Ctr, Clin Res, 6400 Perkins Rd, Baton Rouge, LA 70808 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
22962
引用
收藏
页码:E283 / E283
页数:1
相关论文
共 50 条
  • [1] Semaglutide and cardiovascular outcomes in obesity without diabetes
    Basolo, A.
    Fierabracci, P.
    Salvetti, G.
    Santini, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2024, 47 (05) : 1047 - 1049
  • [2] SEMAGLUTIDE, INFLAMMATORY MARKERS AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH OVERWEIGHT OR OBESITY IN THE SELECT TRIAL
    Plutzky, Jorge
    Bogdanski, Pawel
    Dagdelen, Selcuk
    Deanfield, John
    Emerson, Scott
    Hovingh, G.
    Kahn, Steven
    Larsen, Signe
    Latkovskis, Gustavs
    Lehrke, Michael
    Hardt-Lindberg, Soren
    Lingvay, Ildiko
    Nicholls, Stephen
    Oral, Tugce
    Terns, Paula Perez
    Rasmussen, Soren
    Ridker, Paul
    Ryan, Donna
    Lincoff, A. Michael
    ATHEROSCLEROSIS, 2024, 395
  • [3] Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
    Lincoff, A. Michael
    Brown-Frandsen, Kirstine
    Colhoun, Helen M.
    Deanfield, John
    Emerson, Scott S.
    Esbjerg, Sille
    Hardt-Lindberg, Soren
    Hovingh, G. Kees
    Kahn, Steven E.
    Kushner, Robert F.
    Lingvay, Ildiko
    Oral, Tugce K.
    Michelsen, Marie M.
    Plutzky, Jorge
    Tornoe, Christoffer W.
    Ryan, Donna H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (24): : 2221 - 2232
  • [4] Comment on: Semaglutide and cardiovascular outcomes in obesity without diabetes
    A. Basolo
    P. Fierabracci
    G. Salvetti
    F. Santini
    Journal of Endocrinological Investigation, 2024, 47 : 1047 - 1049
  • [5] Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) Outcomes by Sex
    Verma, Subodh
    Colhoun, Helen M.
    Dicker, Dror
    Hovingh, G. Kees
    Kahn, Steven E.
    Kautzky-Willer, Alexandra
    Lingvay, Ildiko
    Plutzky, Jorge
    Rasmussen, Soren
    Rathor, Naveen
    Tetens, Soren
    Lincoff, A. Michael
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (17) : 1678 - 1682
  • [6] SELECT semaglutide to improve outcomes in patients with obesity and cardiovascular disease, also without diabetes
    Gajos, Grzegorz
    CARDIOLOGY JOURNAL, 2024, 31 (05) : 782 - 783
  • [7] Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design
    Ryan, Donna H.
    Lingvay, Ildiko
    Colhoun, Helen M.
    Deanfield, John
    Emerson, Scott S.
    Kahn, Steven E.
    Kushner, Robert F.
    Marso, Steve
    Plutzky, Jorge
    Brown-Frandsen, Kirstine
    Gronning, Marianne O. L.
    Hovingh, G. Kees
    Holst, Anders Gaarsdal
    Ravn, Henrik
    Lincoff, A. Michael
    AMERICAN HEART JOURNAL, 2020, 229 : 61 - 69
  • [8] Semaglutide effects on safety and cardiovascular outcomes in patients with overweight or obesity: a systematic review and meta-analysis
    Cleto, Andre Saad
    Schirlo, Joao Matheus
    Beltrame, Mayara
    Gomes, Victor Hugo Oliveira
    Acras, Isabela Hellmann
    Neiverth, Guinter Sponholz
    Silva, Breno Bach
    Juliatto, Beatriz Moreira Salles
    Machozeki, Janete
    Martins, Camila Marinelli
    INTERNATIONAL JOURNAL OF OBESITY, 2025, 49 (01) : 21 - 30
  • [9] Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Williams, Thomas C.
    Stewart, Emma
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (09): : 891 - 891
  • [10] Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Marso, Steven P.
    Bain, Stephen C.
    Consoli, Agostino
    Eliaschewitz, Freddy G.
    Jodar, Esteban
    Leiter, Lawrence A.
    Lingvay, Ildiko
    Rosenstock, Julio
    Seufert, Jochen
    Warren, Mark L.
    Woo, Vincent
    Hansen, Oluf
    Holst, Anders G.
    Pettersson, Jonas
    Vilsboll, Tina
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19): : 1834 - 1844